The role of an 'anti-angiogenic state' in complications of pregnancy

Comment

Gian Carlo Di Renzo. J Matern Fetal Neonatal Med. 2008 Jan.

. 2008 Jan;21(1):3-7.

doi: 10.1080/14767050701855081.

No abstract available

Comment on

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA. Romero R, et al. J Matern Fetal Neonatal Med. 2008 Jan;21(1):9-23. doi: 10.1080/14767050701830480. J Matern Fetal Neonatal Med. 2008. PMID: 18175241 Free PMC article.
The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.
Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF, Edwin S, Kusanovic JP, Erez O, Than NG, Hassan SS, Romero R. Chaiworapongsa T, et al. J Matern Fetal Neonatal Med. 2008 Jan;21(1):25-40. doi: 10.1080/14767050701832833. J Matern Fetal Neonatal Med. 2008. PMID: 18175242 Free PMC article.